Caplacizumab (VWF A1 domain) - Research Grade Biosimilar, Unconjugated, Monoclonal

Artikelnummer: PRS-10-476
Artikelname: Caplacizumab (VWF A1 domain) - Research Grade Biosimilar, Unconjugated, Monoclonal
Artikelnummer: PRS-10-476
Hersteller Artikelnummer: 10-476
Alternativnummer: PRS-10-476-0.1
Hersteller: ProSci
Kategorie: Antikörper
Immunogen: Humanized / VWF A1 domain [Homo sapiens]
Konjugation: Unconjugated
Alternative Synonym: ALX-0081,PMP12A2h1-linker AAA-PMP12A2h1,caplacizumab-yhdp
Klonalität: Monoclonal
Konzentration: batch dependent
Puffer: PBS buffer pH7.5
Quelle: CHO cells
Application Verdünnung: Optimal dilutions for each application to be determined by the researcher.